共 50 条
- [38] Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2017, 10 : 47 - 55
- [40] Analysis of Metabolic Syndrome's components by IDF in the female with diabetes mellitus type 2 FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2008, 10 (03): : 624 - 626